April 2, 2025: Zepbound Injuries Are Likely to Increase as Drug is Offered by Major Online Retailer On April 1, online health and wellness retailer Hims & Hers announced that they would be prescribing and selling Zepbound (branded tirzepatide) through their virtual health professionals and online pharmacy
The company describes the patches as crafted to support healthy weight management and appetite control. The new name is better appreciated by our customers, as it more clearly states the main ingredient, Kind Patches said in a statement to TODAY.com
Alexiades: The two forms of radiofrequency (RF) treatments currently in use and most important to GLP-1-related laxity are both skin surface RF modalities
Unlike GLP-1 agonists, berberine does not typically cause nausea through delayed gastric emptying, though gastrointestinal discomfort remains the primary tolerability concern
never in checked luggage
In 2023, Juan P Frias and colleagues, in The Lancet, published the first phase two clinical trial of orforglipron, which investigated the use of a small-molecule oral GLP-1R agonist called orforglipron in type 2 diabetes, which can be taken at any time of the day without restrictions on food and water intake (Frias et al., 2023)